A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India

Clinical trial NCT02117622 · COMPLETED

Trial details

NCT number

NCT02117622

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Study type

OBSERVATIONAL

Start date

2015-07-24

Primary completion

2017-04-05

Enrollment

1056

View on ClinicalTrials.gov